Xeris Biopharma Holdings Stock (NASDAQ: XERS) stock price, news, charts, stock research, profile.
You can purchase shares of Xeris Biopharma Holdings (NASDAQ:XERS) through any online brokerage.
Other companies in Xeris Biopharma Holdings’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD) and GH Research (NASDAQ:GHRS).
Xeris Biopharma Holdings has a consensus price target of $4.87.
The stock price for Xeris Biopharma Holdings (NASDAQ: XERS) is $3.01 last updated November 21, 2024 at 8:06 AM EST.
There are no upcoming dividends for Xeris Biopharma Holdings.
Xeris Biopharma Holdings’s Q3 earnings are confirmed for Friday, November 8, 2024.
There is no upcoming split for Xeris Biopharma Holdings.
Xeris Biopharma Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.